Daratumumab for Refractory and Frequently Relapsing Immune Thrombotic Thrombocytopenic Purpura- a Case Series with Long-Term Follow-up

被引:0
|
作者
Schimmer, Roman R. [1 ,2 ]
van den Berg, Jana [3 ]
Schraner, Marissa [4 ,5 ]
Trinchero, Alice [1 ,2 ]
Holbro, Andreas [3 ]
Hovinga, Johanna A. Kremer [6 ,7 ]
Studt, Jan-Dirk [1 ,2 ]
机构
[1] Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland
[2] Univ Zurich, Zurich, Switzerland
[3] Univ Hosp Basel, Div Hematol, Basel, Switzerland
[4] Univ Hosp Bern, Dept Hematol, Cent Hematol Lab, Bern, Switzerland
[5] Univ Bern, Bern, Switzerland
[6] Univ Bern, Bern Univ Hosp, Dept Hematol, Bern, Switzerland
[7] Univ Bern, Bern Univ Hosp, Cent Hematol Lab, Inselspital Bern, Bern, Switzerland
关键词
D O I
10.1182/blood-2024-208584
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4003 / 4004
页数:2
相关论文
共 50 条
  • [1] Daratumumab for frequently relapsing and refractory immune thrombotic thrombocytopenic purpura
    van den Berg, J.
    Hovinga, J. A. Kremer
    Holbro, A.
    Studt, J. -D.
    SWISS MEDICAL WEEKLY, 2021, 151 : 18 - 18
  • [2] Rituximab therapy for chonic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis
    Garcia-Chavez, Jaime
    Majluf-Cruz, Abraham
    Montiel-Cervantes, Laura
    Esparza, Miriam Garcia-Ruiz
    Vela-Ojeda, Jorge
    ANNALS OF HEMATOLOGY, 2007, 86 (12) : 871 - 877
  • [3] Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab
    Chemnitz, Jens Marcus
    Uener, Jens
    Hallek, Michael
    Scheid, Christof
    ANNALS OF HEMATOLOGY, 2010, 89 (10) : 1029 - 1033
  • [4] Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab
    Jens Marcus Chemnitz
    Jens Uener
    Michael Hallek
    Christof Scheid
    Annals of Hematology, 2010, 89 : 1029 - 1033
  • [5] Rituximab therapy for chonic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis
    Jaime Garcia-Chavez
    Abraham Majluf-Cruz
    Laura Montiel-Cervantes
    Miriam García-Ruiz Esparza
    Jorge Vela-Ojeda
    Annals of Hematology, 2007, 86 : 871 - 877
  • [6] A Long-Term Follow-Up Study in Immune-Mediated Thrombotic Thrombocytopenic Purpura: What Are the Outcomes?
    Bonifacio, Maria Addolorata
    Roselli, Daniele
    Schifone, Claudia Pia
    Ricco, Alessandra
    Vitucci, Angelantonio
    Aprile, Lara
    Mariggio, Maria Addolorata
    Ranieri, Prudenza
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [7] Increased morbidity during long-term follow-up of survivors of thrombotic thrombocytopenic purpura
    Chaturvedi, Shruti
    Abbas, Hashim
    McCrae, Keith R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) : E208 - E208
  • [8] Long-term follow-up of laparoscopic splenectomy in patients with immune thrombocytopenic purpura
    Kang, Chang Moo
    Lee, Jae Gil
    Kim, Kyung Silk
    Choi, Jin Sub
    Lee, Woo Jung
    Kim, Byong Ro
    Ko, Yoon Woong
    Han, Ji Sook
    Min, Yoo Hong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (03) : 420 - 424
  • [9] LONG-TERM FOLLOW-UP OF TWO CHILDREN WITH RECURRENT IMMUNE THROMBOCYTOPENIC PURPURA
    Kaya, Z.
    THROMBOSIS RESEARCH, 2016, 141 : S78 - S79
  • [10] Rituximab Provided Long-Term Remission in a Patient with Refractory Relapsing Thrombotic Thrombocytopenic Purpura
    Satoru Kosugi
    Masanori Matsumoto
    Yasushi Ohtani
    Hironori Take
    Hiromichi Ishizashi
    Yoshihiro Fujimura
    Jun Kuyama
    International Journal of Hematology, 2005, 81 : 433 - 436